AXIM BIOTECHNOLOGIES, INC. Business Finance Contracts & Agreements

30 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Stock Purchase Agreement Between AXIM Biotechnologies, Inc. and Purchaser Dated March 15, 2024
Stock Agreements
AXIM BIOTECHNOLOGIES, INC.
Pharmaceuticals
CA
2024
Description of Securities Registered Under Section 12 – AXIM Biotechnologies, Inc.
Equity Distribution Agreements
AXIM BIOTECHNOLOGIES, INC.
Pharmaceuticals
CA
2023
Stock Purchase Agreement between AXIM Biotechnologies, Inc. and Versea Holdings Inc. dated July 23, 2022
Stock Agreements
AXIM BIOTECHNOLOGIES, INC.
Pharmaceuticals
CA
2022
Stock Purchase Agreement between AXIM Biotechnologies, Inc. and Catalina Valencia dated August 24, 2022
Stock Agreements
AXIM BIOTECHNOLOGIES, INC.
Pharmaceuticals
CA
2022
Asset Purchase Agreement between Advanced Tear Diagnostics, LLC and AXIM Biotechnologies, Inc. dated August 26, 2021
Purchase Agreements
AXIM BIOTECHNOLOGIES, INC.
Pharmaceuticals
CA
2022
Binding Term Sheet for Acquisition of Advanced Tear Diagnostics, LLC by AXIM Biotechnologies, Inc.
Purchase Agreements
AXIM BIOTECHNOLOGIES, INC.
Pharmaceuticals
DE
2022
Equity Purchase Agreement between AXIM Biotechnologies, Inc. and Cross & Company dated May 14, 2021
Purchase Agreements
AXIM BIOTECHNOLOGIES, INC.
Pharmaceuticals
CA
2021
Amendment No. 1 to Stock Purchase Agreement between Axim Biotechnologies, Inc. and Cross & Company (December 16, 2019)
Purchase Agreements
AXIM BIOTECHNOLOGIES, INC.
Pharmaceuticals
2019
PREFERRED STOCK PURCHASE AGREEMENT
Stock Agreements
AXIM BIOTECHNOLOGIES, INC.
Pharmaceuticals
CA
2019
Debt Exchange Agreement between Axim Biotechnologies, Inc. and Atlas Sciences, LLC (November 28, 2018)
Exchange Agreements
AXIM BIOTECHNOLOGIES, INC.
Pharmaceuticals
UT
2018
Securities Purchase Agreement between AXIM Biotechnologies, Inc. and Atlas Sciences, LLC dated November 28, 2018
Purchase Agreements
AXIM BIOTECHNOLOGIES, INC.
Pharmaceuticals
UT
2018
Stock Purchase Agreement between AXIM Biotechnologies, Inc. and Cross & Company dated April 16, 2018
Stock Agreements
AXIM BIOTECHNOLOGIES, INC.
Pharmaceuticals
CA
2018
Description of Securities Registered Under Section 12 – AXIM Biotechnologies, Inc.
Equity Distribution Agreements
AXIM BIOTECHNOLOGIES, INC.
Pharmaceuticals
CA
2024
Axim Biotechnologies, Inc. Convertible Promissory Note Dated March 15, 2024
Note Agreements
AXIM BIOTECHNOLOGIES, INC.
Pharmaceuticals
CA
2024
Axim Biotechnologies, Inc. Convertible Promissory Note Dated March 15, 2024
Note Agreements
AXIM BIOTECHNOLOGIES, INC.
Pharmaceuticals
CA
2024
Axim Biotechnologies, Inc. Convertible Promissory Note Dated March 15, 2024
Note Agreements
AXIM BIOTECHNOLOGIES, INC.
Pharmaceuticals
CA
2024
Convertible Note Purchase Agreement between AXIM Biotechnologies, Inc. and Purchaser (March 15, 2024)
Note Agreements
AXIM BIOTECHNOLOGIES, INC.
Pharmaceuticals
CA
2024
Axim Biotechnologies, Inc. $100,000 Convertible Note Agreement with Medical Marijuana, Inc. dated December 26, 2023
Note Agreements
AXIM BIOTECHNOLOGIES, INC.
Pharmaceuticals
CA
2023
Convertible Note Purchase Agreement between AXIM Biotechnologies, Inc. and Medical Marijuana, Inc. dated December 26, 2023
Note Agreements
AXIM BIOTECHNOLOGIES, INC.
Pharmaceuticals
CA
2023
Equity Purchase Agreement between AXIM Biotechnologies, Inc. and Cross & Company dated June 1, 2023
Equity Distribution Agreements
AXIM BIOTECHNOLOGIES, INC.
Pharmaceuticals
CA
2023
Axim Biotechnologies, Inc. Convertible Promissory Note Agreement (May 23, 2023)
Note Agreements
AXIM BIOTECHNOLOGIES, INC.
Pharmaceuticals
NV
2023
Convertible Note Modification and Default Waiver Agreement between Medical Marijuana, Inc. and Axim Biotechnologies, Inc. dated January 23, 2023
Modification Agreements
AXIM BIOTECHNOLOGIES, INC.
Pharmaceuticals
CA
2023
Convertible Notes Modification and Default Waiver Agreement among TL-66 LLC, Axim Biotechnologies, Inc., and Sapphire Biotechnologies, Inc.
Modification Agreements
AXIM BIOTECHNOLOGIES, INC.
Pharmaceuticals
CA
2023
Equity Purchase Agreement between AXIM Biotechnologies, Inc. and Cross & Company dated July 14, 2022
Equity Distribution Agreements
AXIM BIOTECHNOLOGIES, INC.
Pharmaceuticals
CA
2022
Description of Securities Registered Under Section 12 – AXIM Biotechnologies, Inc.
Equity Distribution Agreements
AXIM BIOTECHNOLOGIES, INC.
Pharmaceuticals
CA
2022
6% Convertible Redeemable Note Agreement between AXIM Biotechnologies, Inc. and GS Capital Partners, LLC (September 29, 2021)
Note Agreements
AXIM BIOTECHNOLOGIES, INC.
Pharmaceuticals
NY
2022
Axim Biotechnologies, Inc. 3% Short Term Convertible Promissory Note Agreement (February 10, 2022)
Note Agreements
AXIM BIOTECHNOLOGIES, INC.
Pharmaceuticals
NV
2022
Axim Biotechnologies, Inc. 1.5% Short Term Promissory Note Dated February 10, 2022
Note Agreements
AXIM BIOTECHNOLOGIES, INC.
Pharmaceuticals
CA
2022
Equity Purchase Agreement between AXIM Biotechnologies, Inc. and Cross & Company dated May 14, 2021
Equity Distribution Agreements
AXIM BIOTECHNOLOGIES, INC.
Pharmaceuticals
CA
2021
Axim Biotechnologies, Inc. and Atlas Sciences, LLC Convertible Promissory Note Agreement
Note Agreements
AXIM BIOTECHNOLOGIES, INC.
Pharmaceuticals
CA
2018